Home › Funds › Defilade Capital Management, L.P. › ZBH

Defilade Capital Management, L.P. position in ZBH

ZIMMER BIOMET HLDGS INC COM · Health Care

Defilade Capital Management, L.P. reported holding 317,426 shares of ZBH (ZIMMER BIOMET HLDGS INC COM) in its Q2 2026 13F filing — a position valued at US$27.3M, representing 3.66% of its reported portfolio and ranking #8 among its reported holdings. Defilade Capital Management, L.P. has disclosed ZBH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)317.43K sh
Reported value held$27.33M
Portfolio Weight3.66%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Defilade Capital Management, L.P.'s ZBH position evolved

Defilade Capital Management, L.P. first disclosed a stake in ZBH in Q1 2026 at 579,161 shares (US$52.4M). Across 2 filings, Defilade Capital Management, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 317,426 shares valued at US$27.3M — a reduction of -261,735 shares quarter over quarter.. Notable position changes include a 45% trim in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 579.16K $52.37M New
Q2 2026 317.43K $27.33M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBH and 13F data

ZBH (ZIMMER BIOMET HLDGS INC COM) is a Health Care company. 20 other funds we track also report a position in ZBH — the largest reported positions include Dodge & Cox (US$2.08B), DODGE & COX (US$2.08B), Harris Associates (Oakmark) (US$1.10B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBH

All ZBH fund holders →

FAQ

How long has Defilade Capital Management, L.P. held ZBH?

Defilade Capital Management, L.P. has disclosed ZBH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Defilade Capital Management, L.P.'s current position in ZBH?

As of Q2 2026, Defilade Capital Management, L.P. holds 317.43K shares of ZBH (ZIMMER BIOMET HLDGS INC COM), valued at $27.33M, representing 3.66% of its reported portfolio and ranking #8.

Has Defilade Capital Management, L.P. been buying or selling ZBH?

In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. reduced its position in ZBH.

Which other funds hold ZBH?

Other major institutional holders of ZBH include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.